Abnormalities in S-adenosylhomocysteine hydrolysis, ATP catabolism, and lymphoid differentiation in adenosine deaminase deficiency.
Abnormalities in S-adenosylhomocysteine hydrolysis, ATP catabolism, and lymphoid differentiation in adenosine deaminase deficiency.
复制标题
腺苷脱氨酶缺乏症导致 S-腺苷同型半胱氨酸水解、ATP 分解代谢和淋巴分化异常。
DOI:
10.1111/j.1749-6632.1985.tb27098.x
复制
发表时间:
1985
影响因子:
5.2
通讯作者:
Schiff,R
中科院分区:
文献类型:
--
作者:
Hershfield,MS;Kurtzberg,J;Aiyar,VN;Suh,EJ;Schiff,R
The discoveries by Giblett and her collaborators of the associations between deficiencies of adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) and selective immunodeficiency diseases','have posed challenging questions to biochemists and immunologists. What are the biochemical consequences of these enzyme deficiencies and how do they lead to selective immune dysfunction? Are there specific ways in which purine metabolism regulates normal development, viability, or function of the immune system? The list of biochemical consequences of ADA and to a lesser degree PNP deficiency is, if not complete, extensive.'The manner in which some or all of these effects lead to selective lymphopenia is not yet clear. Most of our research of the past several years has dealt with defining the biochemical effects of the purine nucleoside substrates of adenosine deaminase. In particular we have examined the effects of adenosine (Ado) and deoxyadenosine (dAdo) on the enzyme S-adenosylhomocysteine (AdoHcy) hydrolase, the regulation of dAdoinduced dATP pool expansion, and the mechanism of dATP-induced ATP depletion. Our initial work was conducted with cultured human lymphoid cell lines treated with the ADA inhibitors 9-erythro-(2-hydroxy-3-nonyl) adenine (EHNA) or deoxycoformycin (do. We have extended our in vitro observations to the in vivo situation in studies of several children with ADA and PNP deficiency whom we have diagnosed at Duke University Medical Center. We have also obtained useful and intriguing information by studying in depth the biochemical and biological consequences of acute ADA deficiency in patients with T cell leukemias during their treatment with dCF. I would like to briefly review our work on AdoHcy metabolism and describe some studies of an ADA-deficient child that relate primarily to the effect of dATP accu-